Reviewed clinical summary · Source-linked · Educational use only

Does the MyBFF@school Program Improve Kids’ Heart and Metabolic Health?

Visual abstract summarising MyBFF school cardiometabolic outcomes in overweight schoolchildren.

Clinical Bottom Line

A 6-month school-based MyBFF@school program improved fasting insulin, HOMA-IR, and HDL-C versus standard schooling in overweight Malaysian children, though BMI still rose. PICO summary and expert commentary.

Summary: In overweight and obese Malaysian primary schoolchildren, a 6-month school-based MyBFF@school program combining physical activity, nutrition, and psychological components produced significantly greater improvements than standard schooling in fasting insulin (-3.16 vs -1.05 microU/mL), HOMA-IR (-0.41 vs -0.17), and HDL-C (+0.34 vs +0.11 mmol/L), all with between-group p<0.001. BMI itself still rose in both arms, and the TG:HDL-C ratio improved equally in both groups.

PICO Summary

ElementDetail
PopulationOverweight and obese primary schoolchildren (BMI z-score > +1 SD) in Malaysia; cluster RCT across 23 of 1196 government schools; 1397 recruited, 683 with paired fasting bloods analysed (intervention 390, control 293).
Intervention6-month MyBFF@school program (physical activity, nutrition, and psychological components) delivered during school hours; n=390 with fasting bloods.
ComparisonStandard school curriculum without the added program; n=293 with fasting bloods.
OutcomeFasting insulin fell more in the intervention arm (-3.16 microU/mL, 95% CI -4.07 to -2.25, p<0.001) than control (-1.05, 95% CI -2.28 to 0.18, p=0.095); between-group p<0.001. HOMA-IR: -0.41 (95% CI -0.63 to -0.19, p<0.001) vs -0.17 (95% CI -0.45 to 0.11, p=0.231); between-group p<0.001. HDL-C rose +0.34 mmol/L (95% CI 0.32 to 0.36, p<0.001) vs +0.11 (95% CI 0.08 to 0.14, p<0.001); between-group p<0.001. BMI z-score held steady in the intervention arm but rose in control (mean difference 0.03, p=0.026). TG:HDL-C ratio fell in both arms with no between-group difference (p=0.524). No ARR/NNT reported (continuous outcomes).
RCT BMC Public Health · 2025

MyBFF@school cardiometabolic outcomes

Cluster RCT · overweight schoolchildren · 6 months

Trial design
Overweight children, Malaysia Enrolled & assessed RANDOMISED cluster MyBFF@school PA + nutrition + psych n = 390 Standard school Usual curriculum n = 293 Change in fasting insulin (microU/mL)
Change from baseline — both arms
microU/mL change Baseline Month 6 -3.16 vs -1.05 microU/mL MyBFF@school Standard school
Fasting insulin
-3.16 vs -1.05
microU/mL, p<0.001
HOMA-IR
-0.41 vs -0.17
p<0.001 between
HDL-C
+0.34 vs +0.11
mmol/L, p<0.001
BMI z-score
steady vs rose
MD 0.03, p=0.026
⬡ Bottom Line

A 6-month multi-component school program reduced fasting insulin and HOMA-IR and raised HDL-C more than usual schooling, but absolute BMI still rose and outcomes are surrogate markers.

Expert Commentary

This cluster randomised trial offers reasonably encouraging evidence that a structured, multi-component school program can shift cardiometabolic markers in children carrying excess weight. The verdict is cautiously positive: fasting insulin, HOMA-IR, and HDL-C all moved further in the intervention arm, and the between-group differences reached statistical significance. The signal on insulin resistance is the most clinically interesting, since it points toward a real reduction in early diabetes risk rather than cosmetic weight change. Some perspective is warranted, however. The headline outcomes are surrogate laboratory markers, not hard endpoints, and absolute weight was not reduced; BMI still climbed in both arms, with the program only preventing the further z-score drift seen in controls. The single most important limitation is attrition and selection: only 683 of 1397 recruited children had paired fasting bloods, so the analysed sample is roughly half of those enrolled, which can flatter an effect. The trial was unblinded by design, as school-based programs cannot be masked, and it was government-funded by the Ministry of Health rather than industry, which is reassuring. Can I use this with my patients? Partly. It is a fair basis to endorse comprehensive school-based programs for overweight children where they exist, but it does not justify promising individual families measurable metabolic gains. Wider trials reporting completer-adjusted analyses and longer follow-up are needed before firmer claims are made.

References

Jalaludin MY, Wan Mohd Zin RM, Roslan FA, Mansor F, Md Zain F, Hong JYH, et al. Cardiometabolic outcome of MyBFF@school intervention program among primary schoolchildren: a cluster randomized controlled trial. BMC Public Health. 2025;24(Suppl 1):3630. doi:10.1186/s12889-025-23546-x

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.